Answers are grounded in this paper and cite their sources.
SUMMARY: : The thickened collagen layer found subepithelially in colorectal biopsies from patients with collagenous colitis consists partly of collagen type III. Procollagen III propeptide (P-III-NP) is a product of collagen III metabolism. We analyzed serum levels of this propeptide to assess its diagnostic value in collagenous colitis. Serum from 38 patients with collagenous colitis and 38 age- and sex-matched controls were analyzed for P-III-NP. Data on the patients included duration and severity of symptoms, treatment, and thickness of the collagen layer. There was no significant difference between P-III-NP in patients (3.8 ± 2.0 μg/L) and controls (3.7 ± 1.3 μg/L), and P-III-NP did not correlate with clinical activity. There was a significant correlation, however, between P-III-NP and age both in patients (r = 0.57, p = 0.0009) and controls (r = 0.64, p = 0.0001). This study shows that P-III-NP is not useful as a diagnostic or prognostic tool in collagenous colitis, and a colonoscopy with biopsy is still the only diagnostic method available.
No takes yet. Share an insight, caveat, or question.
Bohr et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: